MedPath

Lanthanum carbonate

Generic Name
Lanthanum carbonate
Brand Names
Fosrenol
Drug Type
Small Molecule
Chemical Formula
C3La2O9
CAS Number
587-26-8
Unique Ingredient Identifier
0M78EU4V9H

Overview

Lanthanum carbonate is a phosphate binder commonly used in clinical practice. It is marketed under the trade name Fosrenol by Shire Pharmaceuticals. It is the largest of all pills filled in community pharmacies. Sometimes patients forget that Fosrenol is not swallowed whole, but instead should be chewed. This has led to severe choking. It is prescribed for treating high phosphate levels, mainly found in patients with chronic kidney disease. Lanthanum should be taken with meals and binds to phosphate in the diet, preventing phosphate absorption in the intestine.

Background

Lanthanum carbonate is a phosphate binder commonly used in clinical practice. It is marketed under the trade name Fosrenol by Shire Pharmaceuticals. It is the largest of all pills filled in community pharmacies. Sometimes patients forget that Fosrenol is not swallowed whole, but instead should be chewed. This has led to severe choking. It is prescribed for treating high phosphate levels, mainly found in patients with chronic kidney disease. Lanthanum should be taken with meals and binds to phosphate in the diet, preventing phosphate absorption in the intestine.

Indication

Used to reduce serum phosphate in patients with end stage renal disease (ESRD).

Associated Conditions

  • Hyperphosphataemia

FDA Approved Products

Lanthanum carbonate
Manufacturer:Cipla USA Inc.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2023/06/13
NDC:69097-934
Lanthanum carbonate
Manufacturer:Exelan Pharmaceuticals, Inc.
Route:ORAL
Strength:1000 mg in 1 1
Approved: 2023/06/13
NDC:76282-478
Lanthanum carbonate
Manufacturer:Exelan Pharmaceuticals, Inc.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2023/06/13
NDC:76282-476
Lanthanum carbonate
Manufacturer:Cipla USA Inc.
Route:ORAL
Strength:1000 mg in 1 1
Approved: 2023/06/13
NDC:69097-936
Lanthanum carbonate
Manufacturer:Teva Pharmaceuticals USA, Inc.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2024/02/07
NDC:0093-5938

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath